Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

404
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

500
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
500
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

484
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
484
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

935
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
935
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Voice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study.

OTO open·2026
Same author

Immunotherapy-Induced Glutamic Acid Decarboxylase 65 Cerebellitis.

Cureus·2026
Same author

Diagnosis and Treatment of Refractory Chronic Cough: An American Broncho-Esophagological Association Expert Consensus Statement.

The Laryngoscope·2026
Same author

Prospective Study of Long-Term Outcomes and the Patient Experience With Superior Laryngeal Nerve Block for Chronic Cough.

The Laryngoscope·2025
Same author

Dysphagia Outcomes in Zenker Diverticulum: A Longitudinal POuCH Study.

The Laryngoscope·2025
Same author

Surveillance for <i>Trichinella</i> infection in U.S. pigs raised under controlled management documents negligible risk for public health.

Food and waterborne parasitology·2024
Same journal

Association Between the Modified Frailty Index and Short-Term Total Thyroidectomy Complications.

The Laryngoscope·2026
Same journal

Discrimination of Pairs of Chemosensory Stimuli in Relation to Respiration.

The Laryngoscope·2026
Same journal

What Safety Precautions Are Recommended When Lasering in the Airway?

The Laryngoscope·2026
Same journal

Success of Anterior Ethmoidal Artery Flaps for Nasal Septal Perforation Repair: A Systematic Review.

The Laryngoscope·2026
Same journal

Laryngeal IgG4-Related Disease: A Systematic Review of Clinical Features and Management.

The Laryngoscope·2026
Same journal

Elevated BMI Is Not Associated With Adverse Outcomes in Open Airway Reconstruction.

The Laryngoscope·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Investigating the Three-dimensional Flow Separation Induced by a Model Vocal Fold Polyp
09:58

Investigating the Three-dimensional Flow Separation Induced by a Model Vocal Fold Polyp

Published on: February 3, 2014

8.9K

Does treatment of paradoxical vocal fold movement disorder decrease asthma medication use?

Scott Kramer1, Brad deSilva1, L Arick Forrest1

  • 1James Care Voice and Swallowing Disorders Clinic, The Ohio State University, Wexner Medical Center, Columbus, Ohio, U.S.A.

The Laryngoscope
|November 19, 2016
PubMed
Summary
This summary is machine-generated.

Diagnosing and treating paradoxical vocal fold movement disorder (PVFMD) significantly reduced asthma medication use in patients. This improvement occurred with symptom relief and regardless of pulmonary function test results.

Keywords:
Paradoxical vocal fold movementasthmavocal cord dysfunction

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

680
Construction and Characterization of a Novel Vocal Fold Bioreactor
11:11

Construction and Characterization of a Novel Vocal Fold Bioreactor

Published on: August 1, 2014

9.6K

Related Experiment Videos

Last Updated: Mar 11, 2026

Investigating the Three-dimensional Flow Separation Induced by a Model Vocal Fold Polyp
09:58

Investigating the Three-dimensional Flow Separation Induced by a Model Vocal Fold Polyp

Published on: February 3, 2014

8.9K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

680
Construction and Characterization of a Novel Vocal Fold Bioreactor
11:11

Construction and Characterization of a Novel Vocal Fold Bioreactor

Published on: August 1, 2014

9.6K

Area of Science:

  • Pulmonology
  • Otolaryngology
  • Respiratory Medicine

Background:

  • Paradoxical vocal fold movement disorder (PVFMD) is often misdiagnosed as asthma, leading to unnecessary medication use.
  • High rates of asthma medication use are observed in patients with PVFMD prior to diagnosis.

Purpose of the Study:

  • To evaluate the impact of PVFMD diagnosis and treatment on asthma medication usage.
  • To assess symptom improvement and correlate outcomes with pulmonary function tests (PFTs).

Main Methods:

  • A prospective observational study involving patients newly diagnosed with PVFMD.
  • Medication use and symptom improvement were tracked via questionnaires at baseline, first follow-up, and 6 months.
  • Pulmonary function tests (PFTs) were reviewed where available.

Main Results:

  • 85% of patients were using asthma medication at presentation.
  • Following diagnosis and treatment, 79% of patients decreased their asthma medication use (P < .001).
  • 82% of patients reported symptom improvement, independent of PFT patterns.

Conclusions:

  • Diagnosis and treatment of PVFMD effectively reduce the need for asthma medication.
  • Symptom improvement in PVFMD patients is associated with decreased asthma medication use.
  • Asthma medication is frequently overused in patients with undiagnosed PVFMD.